Target intelligence / Profile preview

Hyaluronan-binding protein 2 (HABP2)

Target
HABP2
Molecular classification
Enzyme, Serine protease, Extracellular protein, Peptidase S1 family
01

Overview

**Hyaluronan-binding protein 2 (HABP2)** is an extracellular serine protease of the peptidase S1 family, secreted predominantly by hepatocytes, which is proteolytically processed into a mature heterodimer. It binds hyaluronic acid and plays a central role in the regulation of hemostasis, vascular integrity, and fibrinolysis. HABP2 activates inactive pro-urokinase to urokinase and coagulation Factor VII, thus influencing the coagulation cascade and vascular remodeling. Additionally, it exerts tumor-suppressive functions in specific tissues, such as the thyroid. Genetic variants in HABP2 are associated with susceptibility to venous thromboembolism and nonmedullary thyroid cancer. Its enzymatic activity is modulated by hyaluronan fragments and extracellular nucleic acids, linking inflammation and tissue injury to hemostatic regulation[1][2][3][4][5].

Other names
Factor VII-activating proteaseFSAPHepatocyte growth factor activator-like proteinPlasma hyaluronan-binding proteinPHBPHyaluronic acid binding protein 2FVII activatorPlasma hyaluronan-binding serine proteaseHGFALPHBSPNMTC5Factor VII activating proteinFactor seven-activating protease
02

Mechanism of action

Proteolytic cleavage of prourokinase to active urokinase, Activation of coagulation Factor VII, Degradation of tissue factor pathway inhibitor, Regulation via binding hyaluronic acid, Enhancement by extracellular RNA/histones

03

Biological functions

CoagulationFibrinolysisVascular integrity regulationCell adhesionTumor suppressionProteolytic activation of prourokinase and Factor VIIRegulation of endothelial permeability
04

Disease associations

Cardiovascular disease (venous thromboembolism, carotid stenosis, stroke, coronary heart disease)Cancer (nonmedullary thyroid cancer)Acute lung injuryThrombophilia
05

Safety considerations

Disruption of HABP2 function can lead to increased susceptibility to thrombotic disordersImpaired vascular integrityEnhanced risk of strokeCancer predisposition
06

Biomarkers

Germline variants (e.g., G534E) in familial nonmedullary thyroid cancerMarburg I polymorphism for cardiovascular riskFSAP activity in plasma

Beyond the preview

Go deeper on Hyaluronan-binding protein 2 (HABP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronan-binding protein 2 (HABP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call